Gossamer Bio, Inc. (GOSS) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $172.25M | -45.4% |
| 2024 | $315.29M | +1.1% |
| 2023 | $311.92M | +14.5% |
| 2022 | $272.45M | -20.7% |
| 2021 | $343.66M | -36.3% |
| 2020 | $539.43M | +26.4% |
| 2019 | $426.60M | +78.2% |
| 2018 | $239.42M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $172.25M | -45.4% |
| 2024 | $315.29M | +1.1% |
| 2023 | $311.92M | +14.5% |
| 2022 | $272.45M | -20.7% |
| 2021 | $343.66M | -36.3% |
| 2020 | $539.43M | +26.4% |
| 2019 | $426.60M | +78.2% |
| 2018 | $239.42M | — |